| __timestamp | Agios Pharmaceuticals, Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 33534999 |
| Thursday, January 1, 2015 | 141827000 | 1982000 |
| Friday, January 1, 2016 | 220163000 | 2438000 |
| Sunday, January 1, 2017 | 292681000 | 2901000 |
| Monday, January 1, 2018 | 1397000 | 2423000 |
| Tuesday, January 1, 2019 | 1317000 | 24212000 |
| Wednesday, January 1, 2020 | 2805000 | 39872000 |
| Friday, January 1, 2021 | 18777000 | 44152000 |
| Saturday, January 1, 2022 | 1704000 | 55126000 |
| Sunday, January 1, 2023 | 9504000 | 65573000 |
| Monday, January 1, 2024 | 4165000 |
Unleashing insights
In the competitive landscape of biotechnology, cost management is crucial. Over the past decade, Agios Pharmaceuticals, Inc. and Insmed Incorporated have showcased contrasting trajectories in their cost of revenue. From 2014 to 2023, Agios Pharmaceuticals experienced a dramatic 90% decline in cost of revenue, peaking in 2017 and then plummeting to a fraction of its former self by 2022. In stark contrast, Insmed Incorporated's cost of revenue surged by over 1,800% during the same period, reflecting its aggressive expansion and operational scaling. This divergence highlights the strategic differences between the two companies: Agios's focus on streamlining operations versus Insmed's investment in growth. As the biotech industry continues to evolve, these trends offer valuable insights into how companies navigate financial challenges and opportunities.
Cost of Revenue Trends: Pfizer Inc. vs Agios Pharmaceuticals, Inc.
Gilead Sciences, Inc. vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Zoetis Inc. and Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Jazz Pharmaceuticals plc
Cost of Revenue Comparison: Insmed Incorporated vs Xenon Pharmaceuticals Inc.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Corcept Therapeutics Incorporated vs Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Cytokinetics, Incorporated vs Agios Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Perrigo Company plc and Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Agios Pharmaceuticals, Inc. vs Galapagos NV
Cost of Revenue: Key Insights for Agios Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.